tetraethylenepentamine has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, BS; Champlin, R; Couriel, D; Daniely, Y; de Lima, M; Gee, A; Grynspan, F; Hosing, C; Jones, R; Karandish, S; Khouri, I; Komanduri, K; McMannis, J; Nagler, A; Peled, T; Sadeghi, T; Shpall, EJ | 1 |
1 trial(s) available for tetraethylenepentamine and Hematologic Malignancies
| Article | Year |
|---|---|
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
Topics: Adolescent; Adult; Antigens, Differentiation; Cell Culture Techniques; Cells, Cultured; Chelating Agents; Child; Copper; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Ethylenediamines; Female; Fetal Blood; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Time Factors; Tissue Donors | 2008 |